Cencora Acquires Retina Services Business for $1.1 Billion
Cencora, Inc. (NYSE:COR) has acquired a retina services business for $1.1 billion, expanding its specialty healthcare services. The deal is expected to be accretive to earnings and strengthen its existing retina platform, which generated $600 million in revenue and $75 million in EBITDA in 2022. Analysts from UBS and Evercore ISI have expressed optimism about the acquisition.
Tickers: $COR
Topics: acquisition Cencora Inc. pharmaceutical distribution retina services